Clinicians' challenges in managing patients with invasive fungal diseases in seven Asian countries: An Asia Fungal Working Group (AFWG) Survey

Int J Infect Dis. 2020 Jun:95:471-480. doi: 10.1016/j.ijid.2020.01.007. Epub 2020 Jan 13.

Abstract

Background: Invasive fungal diseases (IFD) are a serious threat, but physicians in Asia lack access to many advanced diagnostics in mycology. It is likely that they face other impediments in the management of IFD. A gap analysis was performed to understand the challenges Asian physicians faced in medical mycology.

Methods: The Asia Fungal Working Group (AFWG) conducted a web-based survey on management practices for IFD among clinicians in China, India, Indonesia, Philippines, Singapore, Taiwan and Thailand.

Findings: Among 292 respondents, 51.7% were infectious disease (ID) specialists. Only 37% of respondents had received formal training in medical mycology. They handled only around 2-4 proven cases of each fungal infection monthly, with invasive candidiasis the most common. For laboratory support, the majority had access to direct microscopy (96%) and histopathology (87%), but galactomannan and azole levels were available to 60% and 25% of respondents, respectively. The majority (84%) used clinical parameters for treatment response monitoring, and 77% followed the Infectious Diseases Society of America guidelines. The majority (84%) did not use the services of an ID physician. Where febrile neutropenia was concerned, 74% of respondents used the empirical approach. Only 30% had an antifungal stewardship program in their hospital. Eighty percent could not use preferred antifungals because of cost.

Interpretation: The survey identified inadequacies in medical mycology training, non-culture diagnostics, access to antifungal drugs, and local guidelines as the major gaps in the management of IFDs in Asian countries. These gaps are targets for improvement.

Keywords: Antifungal management strategies; Education; Mycology practice; Treatment guidelines.

MeSH terms

  • Antifungal Agents / therapeutic use
  • Candidiasis, Invasive / therapy
  • China
  • Clinical Competence
  • Education, Medical
  • Galactose / analogs & derivatives
  • Humans
  • India
  • Indonesia
  • Invasive Fungal Infections / drug therapy
  • Invasive Fungal Infections / therapy*
  • Mannans / metabolism
  • Mycology / education
  • Philippines
  • Singapore
  • Surveys and Questionnaires
  • Taiwan
  • Thailand

Substances

  • Antifungal Agents
  • Mannans
  • galactomannan
  • Galactose